Center News
UCDC hosted congressional visit
Congressman Gary Palmer (AL-06) toured the UAB Comprehensive Diabetes Center (UCDC) on Wednesday, September 4, to learn more about the state of diabetes in Alabama.
Get to know UCDC Researcher Justin Alexander
Justin Alexander is the Lab Manager and a Researcher in the lab of Sushant Bhatnagar, Ph.D. He recieved his undergraduate degree from Auburn University.
Bril talks MASLD and diabetes with UAB MedCast podcast
UAB Comprehensive Diabetes Center Member and Division of Endocrinology, Diabetes, and Metabolism Assistant Professor Fernando Bril, M.D., recently sat down with UAB MedCast podcast to talk about metabolic dysfunction-associated steatotic liver disease (MASLD) and diabetes.
Bhatnagar secures NIH award to continue Type 2 diabetes insulin secretion research
UAB Division of Endocrinology, Diabetes, and Metabolism Associate Professor and Scientist in the Comprehensive Diabetes Center Sushant Bhatnagar, Ph.D., was awarded a prestigious one-year R56 grant from the National Institutes of Health (NIH).
Ramanadham discovers important roles of T-cell lipid signaling in Type 1 diabetes development
Sasanka Ramanadham, Ph.D., and collaborators, published an article entitled “Differential lipid signaling from CD4+ and CD8+ T cells contributes to Type 1 (T1D) diabetes development” in the peer-reviewed journal Frontiers in Immunology.
Shalev Lab shines light on a new, up-and-coming class of Type 1 diabetes medications
The scientific journal Frontiers in Endocrinology just published a peer-reviewed perspective article by UAB Comprehensive Diabetes Center (UCDC) Director Anath Shalev, M.D., entitled “A novel class of oral, non-immunosuppressive, beta cell-targeting, TXNIP-inhibiting T1D drugs is emerging”. Other authors from the Shalev Lab include Gu Jing, Ph.D., and SeongHo Jo, Ph.D.
Basu studies the difference in post-prandial glucose turnover between adolescents and adults with Type 1 diabetes
Ananda Basu, M.D., and researchers recently studied the difference in post-prandial glucose turnover between adolescents and adults with Type 1 diabetes (T1D).
Shalev gives invited presentation on TXNIP at the Levine-Riggs Symposium
UAB Comprehensive Diabetes Center (UCDC) Director Anath Shalev, M.D., recently presented at the prestigious 2024 Rachmiel Levine-Arthur Riggs Diabetes Research Symposium (Levine-Riggs Symposium), held in Pasadena, CA, which is organized by City of Hope®, one of the leading research centers for diabetes and other life-threatening illnesses.
Ramanadham discovers macrophage lipid signaling is a critical contributor to Type 1 diabetes development
Sasanka Ramanadham, Ph.D., and researchers published “Selective Reduction of Ca2+-Independent Phospholipase A2β (iPLA2β)-Derived Lipid Signaling from Macrophages Mitigates Type 1 Diabetes Development"in the peer-reviewed journal Diabetes.
UCDC releases video showcasing its faculty experience

- Shalev and Habegger secure $3 million grant to study novel liver disease drug
- Basu lab investigates hyperglycemia’s effect during exercise in Type 1 diabetes
- Bril and researchers shine light on relationship between insulin resistance and MASLD
- Alsharif receives Graduate Biomedical Sciences award for mentorship